Contact
Please use this form to send email to PR contact of this press release:
PATIENT IMPACT STATEMENT: FDA APPROVAL OF KERENDIA TO HELP SLOW KIDNEY DISEASE, FAILURE ASSOCIATED WITH TYPE 2 DIABETES
TO:
Jennifer Rate
The American Association of Kidney Patients
+1 8134002394